Intuitive Surgical stock gets a Buy rating as Q2 growth holds

Published on 10/06/2026 at 18:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock receives a USD 500.00 Citi target after Q2 revenue reached USD 2.89 billion, up 19 percent year over year. The Nasdaq quote was USD 405.62 on October 6.

Bauhaus-Poster mit geometrischem Roboterarm-Motiv und dem Schriftzug MEDTECH — Geometrisches Bauhaus-Poster mit Sektor-Text MEDTECH visualisiert Intuitive Surgical Inc. (US46120E6023) als Vertreter der Chirurgie-Robotik-Branche, Illustration mit AI erstellt.

Intuitive Surgical stock was trading at USD 405.62 on Nasdaq on October 6, 2026, while Citi maintained a Buy rating and set a USD 500.00 price target. The latest quarter showed revenue growth of 19 percent, but slower US procedure growth gives investors a clear counterweight.

Citi keeps its USD 500 target

According to Markets Insider on October 5, 2026, Citi analyst Joanne Wuensch maintained a Buy rating and set a USD 500.00 target. The same report said RBC Capital maintained a Buy rating on October 1 with a USD 575.00 target, giving the analyst backdrop a wide range of published views.

That Citi target stands 23.3 percent above the USD 405.62 Nasdaq price. The comparison matters because Intuitive Surgical is valued at USD 143.3 billion, so additional share-price upside depends on procedure growth continuing to support the company's premium valuation.

Q2 revenue rose 19 percent

In its Q2 2026 earnings call on July 16, Fortune reported revenue of USD 2.89 billion, up 19 percent from the prior year. GAAP net income reached USD 818 million, compared with USD 658 million in Q2 2025, while GAAP earnings per share rose to USD 2.29 from USD 1.81.

The operating picture was mixed beneath the headline growth. Total procedures increased 16 percent in Q2 2026, with da Vinci procedures up 15 percent and Ion procedures up 36 percent. US da Vinci procedure growth was 12 percent, compared with 20 percent outside the United States, according to the earnings-call transcript.

USD 405.62 quote remains the anchor

The Nasdaq quote stood at USD 405.62 at 11:59 a.m. EDT on October 6, 2026, down USD 0.86 or 0.21 percent from the prior close. The session range was USD 402.13 to USD 409.29, and trading volume had reached 385,787 shares.

For investors, the central test is whether the 13.5 percent to 15.5 percent 2026 da Vinci procedure-growth outlook can absorb slower US demand and preserve the strong recurring-revenue profile described in the Q2 call.